Loading...
NPI 1174092548 · Milledgeville, GA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Med-lake Laboratory, LLC is a clinical medical laboratory provider located in Milledgeville, Georgia. This profile covers 104 Medicare and 154 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Med-lake Laboratory, LLC |
| Address | 100 Industrial Park Rd Nw |
| City | Milledgeville |
| State | GA |
| ZIP | 31061 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | November 15, 2018 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $14.2M |
| Medicare | $2.4M |
The provider’s payer mix is strongly Medicaid‑weighted: lifetime revenue lists Total Medicare revenue of $2.4M compared with Total Medicaid revenue of $14.2M, indicating Medicaid is the dominant source of scale for this lab’s services rather than Medicare. Both payers are present, but Medicaid constitutes the larger share of billing volume and dollars.
The operation is heavily focused on definitive and presumptive drug testing alongside routine clinical chemistry: high‑revenue codes are dominated by drug testing (G0481, G0482, G0480 and 80307) while common clinical panels and assays (82306, 84443, 80061, 80053, 83036) appear further down the payer lists. On Medicare G0481 alone generated $1M (45.6% of Medicare revenue) and on Medicaid G0482 and G0481 together generated $3.5M (27.0%) and $3.3M (24.9%) respectively, underscoring a toxicology/forensic testing service line with supplementary routine lab testing.
Revenue is highly concentrated in a few codes on both payers: the precomputed top 3 Medicare codes account for 74.4% of this provider's total Medicare revenue, and the precomputed top 3 Medicaid codes account for 72.5% of this provider's total Medicaid revenue. This concentration means changes to reimbursement or utilization for those specific drug‑testing codes would disproportionately affect overall revenue.
National competitive standing for the provider’s lead Medicare drug‑test code is extreme: G0481 on Medicare produced $1M and the provider ranks #6 of 1766 nationally (100th percentile; extreme outlier, far above typical national volume for this code). The provider also ranks highly on Medicare 80307 (#35 of 4760, 99th percentile; notably above typical national volume), indicating unusually high national activity in both presumptive and definitive drug testing relative to most labs.
Statewide competitive standing on Medicaid is dominant for drug testing: the provider ranks #1 of 26 in-state for G0482 and #1 of 26 in-state for G0481 (both 100th percentile; extreme outlier, far above typical state volume), with G0482 yielding $3.5M and G0481 yielding $3.3M of Medicaid revenue. 80307 is also a top Medicaid performer (112.3K claims, $2.7M revenue) and ranks #2 of 68 in-state (99th percentile; notably above typical state volume), collectively signaling market leadership in Georgia for toxicology testing.
Medicaid claim volume for the top drug‑testing codes far exceeds Medicare claim counts for the same codes: examples include Medicaid claims of 61.8K for G0481, 59.1K for G0482 and 112.3K for 80307 versus Medicare claims of 6.6K (G0481), 1.4K (G0482) and 6.2K (80307). This pattern points to substantially higher throughput and dependence on Medicaid‑sourced testing volume compared with Medicare.
The provider’s NPI tenure is relatively recent but established: NPI enumerated 2018-11-15 (~8 years ago). Achieving the observed statewide dominance in Medicaid drug‑testing codes and high national placement on Medicare drug testing within this period suggests rapid scaling of toxicity testing capacity and payer relationships since enumeration.
While the lab shows some diversification into routine clinical testing, those lines are much smaller relative to toxicology revenue—examples on Medicare include 82306 ($61.9K, 2.8% of Medicare revenue) and 80061 ($53.6K, 2.4% of Medicare revenue). Given the heavy reliance on a few high‑value drug‑testing codes, the provider has both an operational strength in toxicology and a business sensitivity to policy or market shifts affecting those specific codes.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
104 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 6,600 | $150 | $1M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 6,150 | $60 | $369.1K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1,380 | $190 | $264.4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1,230 | $110 | $136.3K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 2,140 | $30 | $61.9K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 3,550 | $20 | $56.8K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 4,130 | $10 | $53.6K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 4,320 | $10 | $43.2K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 3,060 | $10 | $30.6K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 1,890 | $20 | $28.4K |
Showing 1–10 of 104
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 104 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
154 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 59,060 | $60 | $3.5M |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 61,750 | $50 | $3.3M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 112,310 | $20 | $2.7M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 48,500 | $30 | $1.5M |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 3,660 | $110 | $395.1K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 24,510 | $20 | $392.2K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 1,580 | $180 | $283K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 2,610 | $60 | $164.4K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 7,630 | $10 | $106.8K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 10,760 | $10 | $75.3K |
Showing 1–10 of 154
How this provider's Medicaid billing volume and revenue compare to other Georgia providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Georgia median
154 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 14 | 30 | 2,370 | $100 | $757.4K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 4 | 10 | 140 | $20 | $529.9K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1 | 30 | 860 | $70 | $525.3K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 3 | 30 | 940 | $30 | $467.9K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 2 | 70 | 2,840 | $30 | $428.7K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1 | 30 | 1,130 | $50 | $338.3K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 16 | 40 | 1,100 | $20 | $287.1K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 2 | 20 | 1,130 | $50 | $279.6K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 16 | 40 | 1,160 | $20 | $275.9K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 8 | 20 | 430 | $90 | $241.3K |
Showing 1–10 of 154
Other providers in the same ZIP code as Med-lake Laboratory, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Christopher Bowers Md PC | GA | Pediatrics Physician | $0 | $2.7M |
| Prabhdeep Brar Md PC | GA | Pediatrics Physician | $0 | $2.4M |
| Milledgeville Pediatrics PC | GA | Pediatrics Physician | $0 | $2.1M |
| Sokar Kendor Md PC | GA | Pediatrics Physician | $0 | $2.1M |
| The Woman's Care Center | GA | Obstetrics & Gynecology Physician | $0 | $995.2K |
| Janet Harrison | GA | Dentist | $0 | $884.7K |
| Air Evac Ems, Inc. | GA | Air Ambulance | $459.4K | $0 |
| Charles Brown | GA | Obstetrics & Gynecology Physician | $299.1K | $0 |
| Patrice Boddie | GA | Internal Medicine Physician | $25.9K | $226K |
| Oconee Radiology Associates | GA | Diagnostic Radiology Physician | $0 | $219.1K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.